| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216095 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
Although uncommon, patients with stage I-II MCL can have favorable outcomes. Despite a continued decline in the usage of consolidative RT, combined modality therapy improves survival in this cohort compared with monotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Beant S. MD, John A. MD, Sarah S. MD, Goundappa K. PhD, Sushil MD,